Home/Filings/4/0001209191-21-014866
4//SEC Filing

Owens Edward P 4

Accession 0001209191-21-014866

CIK 0001446847other

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 5:15 PM ET

Size

8.1 KB

Accession

0001209191-21-014866

Insider Transaction Report

Form 4
Period: 2021-02-24
Transactions
  • Purchase

    Class A Common Stock

    2021-02-25$9.11/sh+5,000$45,550215,954 total
  • Purchase

    Class A Common Stock

    2021-02-24$9.26/sh+7,000$64,820210,954 total
Holdings
  • Class A Common Stock

    (indirect: By Foundation)
    40,000
Footnotes (3)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.19 to $9.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.05 to $9.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F3]The reporting person and certain members of his family are trustees of the foundation, the beneficial owner of the securities. The reporting person disclaims beneficial ownership of the securities.

Issuer

IRONWOOD PHARMACEUTICALS INC

CIK 0001446847

Entity typeother

Related Parties

1
  • filerCIK 0001570533

Filing Metadata

Form type
4
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:15 PM ET
Size
8.1 KB